Monocyte Pathogenesis: Regulation of NADPH Oxidase

单核细胞发病机制:NADPH 氧化酶的调节

基本信息

  • 批准号:
    6875800
  • 负责人:
  • 金额:
    $ 34.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The production of superoxide anion (02-) by activated monocytes and neutrophils is an essential element of host defense and inflammation. 02- is generated via the enzyme complex, NADPH oxidase. In addition to its role in killing microorganisms, 02- production contributes to the oxidation of lipids. Lipid oxidation, mediated by monocyte NADPH oxidase, is believed to significantly contribute to atherogenesis. Understanding of the regulation and function of the monocyte NADPH oxidase and 02- production is limited. We are finding that the monocyte NADPH oxidase is regulated very differently than the neutrophil enzyme complex. Since neutrophils are not present in the artery wall, either in early or late lesion development, understanding the regulation of the activity of this enzyme complex in monocytes is paramount. Particular importance of NADPH oxidase in atherogenesis is derived from recent studies showing that the development of atherosclerosis is less in animals deficient in this enzyme. NADPH oxidase is comprised of several components. In resting monocytes some components are membrane-bound while others are cytosolic. The latter must form a membrane-associated complex with other oxidase components to allow enzyme activity. Three critical cytosolic components of NADPH oxidase that translocate to form the active enzyme complex are the focus of this application. They are p47phox, p67phox and Racl. Prior studies from our laboratory have delineated an activation-induced pathway involving increased intracellular calcium, PKCalpha translocation, PKCalpha-dependent phosphorylation and activation of cPLA2, generation of arachidonic acid (AA) and activation of NADPH oxidase. In Aim 1 we propose to identify the critical, PKCalpha-dependent phosphorylation sites on cPLA2 and examine their effects on cPLA2 activity. Comparisons will be made between in vitro generated and monocyte-mediated phosphorylation sites. Studies in Aim 2 explore regulation of NADPH oxidase activity by cPLA2-derived AA and how AA can regulate translocation of NADPH oxidase components. We have new evidence that PKCdelta is involved in the phosphorylation of p47phox. Therefore in the third aim we propose studies to examine the PKCdelta-dependent phosphorylation sites on p47phox and determine their effects on p47phox interaction with other NADPH oxidase components. We will also initiate studies to identify the kinase responsible for phosphorylating p67phox. Studies in Aim 4 will test the hypothesis that Racl is critical for mediating p47phox and p67phox interaction and formation of the active NADPH oxidase complex. Due to the tools that we have developed to probe signal transduction pathways in monocytes, we are in a unique position to specifically identify these pathways and discover novel approaches for influencing inflammatory responses that have developed into pathogenic processes.
描述(由申请人提供):活化的单核细胞和中性粒细胞产生超氧阴离子(O2-)是宿主防御和炎症的基本要素。02-是通过酶复合物NADPH氧化酶产生的。除了其在杀死微生物中的作用之外,O2-产生有助于脂质的氧化。由单核细胞NADPH氧化酶介导的脂质氧化被认为是动脉粥样硬化形成的重要因素。对单核细胞NADPH氧化酶和02-产生的调节和功能的理解是有限的。我们发现单核细胞NADPH氧化酶的调节方式与中性粒细胞酶复合体非常不同。由于中性粒细胞不存在于动脉壁,无论是在早期或晚期病变的发展,了解单核细胞中这种酶复合物的活性调节是至关重要的。NADPH氧化酶在动脉粥样硬化形成中的特别重要性来自于最近的研究,表明动脉粥样硬化的发展在这种酶缺乏的动物中较少。NADPH氧化酶由几种组分组成。在静息单核细胞中,一些组分是膜结合的,而另一些是胞质的。后者必须与其他氧化酶组分形成膜缔合复合物以允许酶活性。NADPH氧化酶的三个关键胞质组分易位形成活性酶复合物是本申请的重点。它们是p47phox、p67phox和Racl。我们实验室先前的研究已经描述了一种激活诱导途径,涉及细胞内钙离子增加、PKCalpha易位、PKCalpha依赖性磷酸化和cPLA2激活、花生四烯酸(AA)生成和NADPH氧化酶激活。在目的1中,我们提出了确定关键的,PKCa依赖的磷酸化位点的cPLA2和检查他们对cPLA2活性的影响。将在体外产生的和单核细胞介导的磷酸化位点之间进行比较。目的2中的研究探索cPLA2衍生的AA对NADPH氧化酶活性的调节以及AA如何调节NADPH氧化酶组分的易位。我们有新的证据表明PKC δ参与p47phox的磷酸化。因此,在第三个目标中,我们提出研究p47 phox上的PKC δ依赖性磷酸化位点,并确定它们对p47 phox与其他NADPH氧化酶组分相互作用的影响。我们还将启动研究,以确定负责磷酸化p67phox的激酶。目的4中的研究将检验Racl对于介导p47phox和p67phox相互作用和活性NADPH氧化酶复合物的形成是关键的假设。由于我们已经开发了探测单核细胞中信号转导通路的工具,我们处于独特的位置,可以特异性地识别这些通路,并发现影响已发展为致病过程的炎症反应的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martha K Cathcart其他文献

Erratum: Writing a first grant proposal
勘误表:撰写第一份拨款提案
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    30.5
  • 作者:
    J. Gomez;Lee;Martha K Cathcart;L. Justement;E. Kovacs;K. Mcleish;W. Nauseef
  • 通讯作者:
    W. Nauseef

Martha K Cathcart的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martha K Cathcart', 18)}}的其他基金

Molecular Medicine Training Program
分子医学培训计划
  • 批准号:
    8077520
  • 财政年份:
    2011
  • 资助金额:
    $ 34.43万
  • 项目类别:
2009 Atherosclerosis Gordon Research Conference
2009年动脉粥样硬化戈登研究会议
  • 批准号:
    7669740
  • 财政年份:
    2009
  • 资助金额:
    $ 34.43万
  • 项目类别:
REGULATION OF MONOCYTE 15-LIPOXYGENASE EXPRESSION
单核细胞 15-脂加氧酶表达的调节
  • 批准号:
    7337247
  • 财政年份:
    2007
  • 资助金额:
    $ 34.43万
  • 项目类别:
Vascular Biology and Medicine 2005/NAVBO Annual Meetings
血管生物学和医学 2005/NAVBO 年会
  • 批准号:
    7000802
  • 财政年份:
    2005
  • 资助金额:
    $ 34.43万
  • 项目类别:
Vascular Biology and Medicine 2005 and NAVBO Annual Meetings
2005 年血管生物学和医学及 NAVBO 年会
  • 批准号:
    7108610
  • 财政年份:
    2005
  • 资助金额:
    $ 34.43万
  • 项目类别:
PHOSPHOLIPASE REGULATION OF MONOCYTE CHEMOTAXIS TO MCP-1
磷脂酶对单核细胞 MCP-1 趋化性的调节
  • 批准号:
    6767717
  • 财政年份:
    2003
  • 资助金额:
    $ 34.43万
  • 项目类别:
PHOSPHOLIPASE REGULATION OF MONOCYTE CHEMOTAXIS TO MCP-1
磷脂酶对单核细胞 MCP-1 趋化性的调节
  • 批准号:
    7077721
  • 财政年份:
    2003
  • 资助金额:
    $ 34.43万
  • 项目类别:
PHOSPHOLIPASE REGULATION OF MONOCYTE CHEMOTAXIS TO MCP-1
磷脂酶对单核细胞 MCP-1 趋化性的调节
  • 批准号:
    6905681
  • 财政年份:
    2003
  • 资助金额:
    $ 34.43万
  • 项目类别:
PHOSPHOLIPASE REGULATION OF MONOCYTE CHEMOTAXIS TO MCP-1
磷脂酶对单核细胞 MCP-1 趋化性的调节
  • 批准号:
    6674594
  • 财政年份:
    2003
  • 资助金额:
    $ 34.43万
  • 项目类别:
MONOCYTE PATHOGENESIS--RESPIRATORY BURST OXIDASE
单核细胞发病机制--呼吸爆发氧化酶
  • 批准号:
    6527587
  • 财政年份:
    1999
  • 资助金额:
    $ 34.43万
  • 项目类别:

相似海外基金

Asymmetric Single-Chain MspA nanopores for electroosmotic stretching and sequencing proteins
用于电渗拉伸和蛋白质测序的不对称单链 MspA 纳米孔
  • 批准号:
    10646810
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Exploring the Role of Nitrogen Metabolism in Cancer
探索氮代谢在癌症中的作用
  • 批准号:
    10737792
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Discovery of neoepitope immunotherapeutic targets in diffuse pediatric high-grade gliomas
弥漫性儿童高级别胶质瘤中新表位免疫治疗靶点的发现
  • 批准号:
    10774404
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Detecting cell to cell contacts in zebrafish with a synthetic receptor methodology
使用合成受体方法检测斑马鱼的细胞与细胞接触
  • 批准号:
    10645331
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
A novel peptide assay for hepcidin clinical monitoring
一种用于铁调素临床监测的新型肽测定方法
  • 批准号:
    10698746
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
  • 批准号:
    10713648
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Identifying the Molecular Function of the Y-linked Mouse Zinc Finger Proteins ZFY1 and ZFY2
鉴定 Y 连锁小鼠锌指蛋白 ZFY1 和 ZFY2 的分子功能
  • 批准号:
    10749409
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
  • 批准号:
    10589578
  • 财政年份:
    2023
  • 资助金额:
    $ 34.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了